Global Propranolol Market Growth 2025-2031

Global Propranolol Market Growth 2025-2031

The global Propranolol market size is predicted to grow from US$ 400 million in 2025 to US$ 484 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.

Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%.

Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent.

In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.

LP Information, Inc. (LPI) ' newest research report, the “Propranolol Industry Forecast” looks at past sales and reviews total world Propranolol sales in 2024, providing a comprehensive analysis by region and market sector of projected Propranolol sales for 2025 through 2031. With Propranolol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propranolol industry.

This Insight Report provides a comprehensive analysis of the global Propranolol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propranolol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Propranolol market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propranolol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propranolol.

This report presents a comprehensive overview, market shares, and growth opportunities of Propranolol market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Oral
Injection

Segmentation by Application:
Arrhythmia
Hypertension
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Apotex
Teva
Atnas Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva

Key Questions Addressed in this Report

What is the 10-year outlook for the global Propranolol market?

What factors are driving Propranolol market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Propranolol market opportunities vary by end market size?

How does Propranolol break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.